SavedAdd your journal

Journals / Bitlis Eren Üniversitesi Fen Bilimleri Dergisi / 2026 / Volume: 15 Issue: 3

An Integrative In Silico Analysis of The Per2–Tp53 Axis In Circadian–Oncogenic Regulation In Breast Carcinogenesis

İlkay Civelek(NİĞDE ÖMER HALİSDEMİR ÜNİVERSİTESİ)0000-0002-8241-1596
Pages
—
Publication Date
2026-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper is based on an original ‘in silico’ study to provide functional insights based on integrated genomic data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Circadian clock dysfunction, often associated with shift work, is classified as a probable carcinogen by the International Agency for Research on Cancer (IARC).
📊
Key Findings & Data:All data is derived from publicly available data via Ensembl/BioMart (version 110) and STRING-DB (version 12.0) databases for a 14-gene panel based on PPI networks.
💡
Conclusion & Impact:This paper is based on an original ‘in silico’ study to provide functional insights based on integrated genomic data.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Circadian rhythm · Breast cancer · PER2-TP53 axis

Abstract

Circadian clock dysfunction, often associated with shift work, is classified as a probable carcinogen by the International Agency for Research on Cancer (IARC). Epidemiological studies suggest a possible link between shift work and breast cancer, but how it specifically connects on the molecular level has not been well elucidated. To address this, an in silico framework is presented, to the best of the author's knowledge, for exploring possible connections between circadian factors and cancer and for generating testable hypotheses for further study. All data is derived from publicly available data via Ensembl/BioMart (version 110) and STRING-DB (version 12.0) databases for a 14-gene panel based on PPI networks. TP53 and PER2 were found to be crucial nodes within the interaction networks, with PER2 showing a non-random centrality with Degree = 8 (empirical p = 0.0034, n = 10,000 permutations). Based upon this observation, an analytical framework is proposed upon which there may be a potential dual vulnerability (‘Double Failure’) within circadian clock function as well as oncogenesis. This paper is based on an original ‘in silico’ study to provide functional insights based on integrated genomic data.

🔖

Cite This Article

Civelek, İ. (2026). An Integrative In Silico Analysis of The Per2–Tp53 Axis In Circadian–Oncogenic Regulation In Breast Carcinogenesis. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi, Volume: 15 Issue: 3. https://doi.org/10.17798/bitlisfen.1896315

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (32)

  1. M. H. Vitaterna, J. S. Takahashi, and F. W. Turek, “Overview of circadian rhythms,” *Alcohol Research & Health*, vol. 25, no. 2, p. 85, 2001.
  2. P. C. Zee, H. Attarian, and A. Videnovic, “Circadian rhythm abnormalities,” *Continuum: Lifelong Learning in Neurology*, vol. 19, no. 1, pp. 132–147, 2013.
  3. W. Ruan, X. Yuan, and H. K. Eltzschig, “Circadian rhythm as a therapeutic target,” *Nature Reviews Drug Discovery*, vol. 20, no. 4, pp. 287–307, 2021.
  4. W. H. Walker, J. C. Walton, A. C. DeVries, and R. J. Nelson, “Circadian rhythm disruption and mental health,” *Translational Psychiatry*, vol. 10, no. 1, Art. no. 28, 2020.
  5. R. V. Khapre, W. E. Samsa, and R. V. Kondratov, “Circadian regulation of cell cycle: Molecular connections between aging and the circadian clock,” *Annals of Medicine*, vol. 42, no. 6, pp. 404–415, 2010.
  6. C. Vetter, D. Fischer, J. L. Matera, and T. Roenneberg, “Aligning work and circadian time in shift workers improves sleep and reduces circadian disruption,” *Current Biology*, vol. 25, no. 7, pp. 907–911, 2015.
  7. S. Davis and D. K. Mirick, “Circadian disruption, shift work and the risk of cancer: A summary of the evidence and studies in Seattle,” *Cancer Causes & Control*, vol. 17, no. 4, pp. 539–545, 2006.
  8. M. Quaas, R. Kohler, L. Nöltner, L. F. Schmidbauer, S. Uxa, G. A. Müller, and K. Engeland, “BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM,” *Cell Death & Differentiation*, vol. 33, no. 1, pp. 51–63, 2026.
  9. T. Gotoh, M. Vila-Caballer, C. S. Santos, J. Liu, J. Yang, and C. V. Finkielstein, “The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells,” *Molecular Biology of the Cell*, vol. 25, no. 19, pp. 3081–3093, 2014.
  10. T. Miki, T. Matsumoto, Z. Zhao, and C. C. Lee, “p53 regulates Period2 expression and the circadian clock,” *Nature Communications*, vol. 4, Art. no. 2444, 2013.
  11. S. M. Ortega-Campos, E. M. Verdugo-Sivianes, A. Amiama-Roig, J. R. Blanco, and A. Carnero, “Interactions of circadian clock genes with the hallmarks of cancer,” *Biochimica et Biophysica Acta (BBA) - Reviews on Cancer*, vol. 1878, no. 3, Art. no. 188900, 2023.
  12. K. Chen, Y. Wang, D. Li, R. Wu, J. Wang, W. Wei, W. Zhu, W. Xie, D. Feng, and Y. He, “Biological clock regulation by the *PER* gene family: A new perspective on tumor development,” *Frontiers in Cell and Developmental Biology*, vol. 12, Art. no. 1332506, 2024.
  13. F. J. Martin, M. R. Amode, A. Aneja, O. Austine-Orimoloye, A. G. Azov, *et al*., “Ensembl 2023,” *Nucleic Acids Research*, vol. 51, no. D1, pp. D933–D941, 2023.
  14. D. Smedley, S. Haider, B. Ballester, R. Holland, D. London, G. Thorisson, and A. Kasprzyk, “BioMart—Biological queries made easy,” *BMC Genomics*, vol. 10, Art. no. 22, 2009.
  15. G. Van Rossum and F. L. Drake, *Python 3 Reference Manual*. Scotts Valley, CA, USA: CreateSpace, 2009.
  16. W. McKinney, “Data structures for statistical computing in Python,” in *Proceedings of the 9th Python in Science Conference*, 2010, pp. 51–56.
  17. M. L. Waskom, “Seaborn: Statistical data visualization,” *Journal of Open Source Software*, vol. 6, no. 60, Art. no. 3021, 2021.
  18. J. D. Hunter, “Matplotlib: A 2D graphics environment,” *Computing in Science & Engineering*, vol. 9, no. 3, pp. 90–95, 2007.
  19. D. Szklarczyk, R. Kirsch, M. Koutrouli, K. Nastou, F. Mehryary, R. Hachilif, *et al*., “The STRING database in 2023: Protein–protein association networks and functional enrichment analyses for any sequenced genome of interest,” *Nucleic Acids Research*, vol. 51, no. D1, pp. D638–D646, 2023.
  20. A. Hagberg, P. J. Swart, and D. A. Schult, “Exploring network structure, dynamics, and function using NetworkX,” in *Proceedings of the 7th Python in Science Conference*, 2008, pp. 11–15.
  21. M. V. Kuleshov, M. R. Jones, A. D. Rouillard, N. F. Fernandez, Q. Duan, Z. Wang, *et al*., “Enrichr: A comprehensive gene set enrichment analysis web server 2016 update,” *Nucleic Acids Research*, vol. 44, no. W1, pp. W90–W97, 2016.
  22. M. Kanehisa, M. Furumichi, Y. Sato, M. Kawashima, and M. Ishiguro-Watanabe, “KEGG for taxonomy-based analysis of pathways and genomes,” *Nucleic Acids Research*, vol. 51, no. D1, pp. D587–D592, 2023.
  23. M. Gillespie, B. Jassal, R. Stephan, M. Milacic, K. Rothfels, A. Senff-Ribeiro, *et al*., “The Reactome pathway knowledgebase 2022,” *Nucleic Acids Research*, vol. 50, no. D1, pp. D687–D692, 2022.
  24. S. A. Aleksander, J. Balhoff, S. Carbon, J. M. Cherry, H. J. Drabkin, D. Ebert, *et al*., “The Gene Ontology knowledgebase in 2023,” *Genetics*, vol. 224, no. 1, Art. no. iyad031, 2023.
  25. M. Martens, A. Ammar, A. Riutta, A. Waagmeester, D. N. Slenter, K. Hanspers, *et al*., “WikiPathways: Connecting communities,” *Nucleic Acids Research*, vol. 49, no. D1, pp. D613–D621, 2021.
  26. E. Cerami, J. Gao, U. Dogrusoz, B. E. Gross, S. O. Sumer, B. A. Aksoy, *et al*., “The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data,” *Cancer Discovery*, vol. 2, no. 5, pp. 401–404, 2012.
  27. S. Gery, R. K. Virk, K. Chumakov, A. Yu, and H. P. Koeffler, “The clock gene *Per2* links the circadian system to the estrogen receptor,” *Oncogene*, vol. 26, no. 57, pp. 7916–7920, 2007.
  28. X. Li, Y. Hu, and F. Aslanbeigi, “Genetic and epigenetic alterations in night shift nurses with breast cancer: A narrative review,” *Cancer Cell International*, vol. 25, no. 1, Art. no. 20, 2025.
  29. S. Vivarelli, T. Formica, Y. Puliatti, G. Spatari, and C. Fenga, “Night shift work and breast cancer: From etiopathology to precision risk analysis,” *npj Breast Cancer*, vol. 11, Art. no. 132, 2025.
  30. E. L. Haus and M. H. Smolensky, “Shift work and cancer risk: Potential mechanistic roles of circadian disruption, light at night, and sleep deprivation,” *Sleep Medicine Reviews*, vol. 17, no. 4, pp. 273–284, 2013.
  31. A. Sancar, L. A. Lindsey-Boltz, T. H. Kang, J. T. Reardon, J. H. Lee, and N. Ozturk, “Circadian clock control of the cellular response to DNA damage,” *FEBS Letters*, vol. 584, no. 12, pp. 2618–2625, 2010.
  32. A. H. Mahdi, Y. Huo, Y. Chen, P. Selenica, A. Sharma, E. Merritt, *et al*., “Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice,” *Genes & Diseases*, vol. 9, no. 3, pp. 807–813, 2022.